Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

336

Figures (1-6)

Tables (1-3)

Sum=463

Publishing Process of This Article

Item

Count

Browse

Download

Sum=63

Jul 26, 2025 (publication date) through Aug 8, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Stem Cells. Jul 26, 2025; 17(7): 108202
Published online Jul 26, 2025. doi: 10.4252/wjsc.v17.i7.108202

Full Size Figure Download Figure

Figure 6 Various non-glycemic effects of mesenchymal stem cell-based therapies on patients with diabetes mellitus. MSC: Mesenchymal stem cell.

Citation: Aringazina RA, Zare A, Mousavi SM, Abenova N, Mussin NM, Tamadon A. Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis. World J Stem Cells 2025; 17(7): 108202
URL: https://www.wjgnet.com/1948-0210/full/v17/i7/108202.htm
DOI: https://dx.doi.org/10.4252/wjsc.v17.i7.108202